Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
US2017239356A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017239356-A1 |
| Application number | US-201515304675-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 16, 2015 |
| Priority date | Apr 17, 2014 |
| Publication date | Aug 24, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a method for producing a hydrogel, which enables a hydrogel comprising polyethylene glycol to be produced under low peroxidase concentration conditions and physiological conditions. The method for producing a hydrogel involves crosslinking polyethylene glycol having two or more thiol groups using peroxidase in the presence of a phenol compound.
Opening claim text (preview).
1 . A method for producing a hydrogel, comprising crosslinking a polyethylene glycol having two or more thiol groups using a peroxidase in presence of a phenol compound. 2 . The method for producing a hydrogel according to claim 1 , wherein the peroxidase is a peroxidase derived from horseradish. 3 . The method for producing a hydrogel according to claim 1 , wherein the phenol compound is at least one of tyramine hydrochloride, phenol, N-glycyl-L-tyrosine, hydroquinone, resorcinol, catechol and serotonin. 4 . The method for producing a hydrogel according to claim 1 , wherein the polyethylene glycol having two or more thiol groups and a thiol compound having one or more thiol groups are crosslinked using the peroxidase in presence of the phenol compound. 5 . The method for producing a hydrogel according to claim 1 , wherein the polyethylene glycol having two or more thiol groups and a phenol compound having one or more thiol groups are crosslinked using the peroxidase. 6 . A method for enveloping an envelopment target, comprising producing a hydrogel by crosslinking a polyethylene glycol having two or more thiol groups using a peroxidase in presence of a phenol compound, and enveloping the envelopment target in the hydrogel. 7 . A method for releasing an envelopment target, comprising releasing an envelopment target, which has been enveloped in a hydrogel by producing a hydrogel by crosslinking a polyethylene glycol having two or more thiol groups using a peroxidase in presence of a phenol compound and in presence of the envelopment target, by dissolving the hydrogel using a reducing agent.
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title
Peroxidase (1.11.1.7), i.e. horseradish-peroxidase · CPC title
Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34) · CPC title
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.